Piper Sandler analysts are cautioning investors about a potential correction in the S&P 500, despite recent highs. Their note ...

MINNEAPOLIS, September 09, 2024--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of Joe Kinder and Brent Blevins as managing directors to its ...

Nancy Lazar, Piper Sandler global chief economist, joins 'Money Movers' to discuss whether Tuesday's economic data changes any of the economists' forecasts, whether the Federal Reserve has room to ...

Estée Lauder Cos. drew an upgrade to overweight from neutral at Piper Sandler on Thursday as analyst Korinne Wolfmeyer said she’s more bullish on the beauty giant after its stock has lost more ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Immunic (IMUX – Research Report) today and set a price target of $28.00. The company’s shares closed last Friday at $1.52.

In a report released today, Edward Tenthoff from Piper Sandler maintained a Buy rating on Moderna (MRNA – Research Report), with a price target of $115.00. The company’s shares closed ...

Shares of Supernus Pharmaceuticals (NASDAQ:SUPN) turned lower on Wednesday after Piper Sandler downgraded the company, citing a more muted growth trajectory for Qelbree, its treatment for ...

Piper Sandler has reaffirmed its positive stance on Nuvalent (NASDAQ: NUVL), maintaining an Overweight rating and a $100.00 price target. The endorsement follows the complete Phase 1 data ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As you can see from the chart above the percentage of shares that are sold short for Piper Sandler has grown since its last report. This does not mean that the stock is going to fall in the near ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...